I saw this posted on the Musella website (virtualtrials.com Brain Tumor news blast 5600):
Tocagen wins "Most Successful Early Phase Trial" and "Excellence in Rare Disease Drug Development" awards! I am proud to say that the Musella Foundation has supported the development of this treatment with $130,000 in grants over the last 5 years. Winning the "Most Successful Early Phase Trial" is really impressive when you consider this is across all cancer types, not just brain tumors. Congratulations to Tocagen!"
Stephen, do you happen to know any details of the results?